Although nuclear FAK IHC staining is associated with a poor prognosis in human colorectal cancer (15) and FAK signaling supports tumor chemotherapy resistance (16), it remains unclear whether FAK nuclear localization contributes to HGSOC cisplatin resistance. Here, PTK2 is linked to neoplasm.